SCHEDULE: Armistice Capital Exits STAAR Surgical Stake

Sentiment:

Schedule 13G Amendment 14 November 2025 6:24 PM

Armistice Capital, LLC and Steven Boyd have reported a complete divestment of their beneficial ownership in STAAR Surgical Co., now holding 0.00% of common stock.

Worse than expectedA significant institutional investor, Armistice Capital, LLC, and its managing member, Steven Boyd, have completely divested their beneficial ownership in STAAR Surgical Co., reducing their stake to 0.00%. This indicates a loss of confidence or a strategic exit from the investment.

Summary

Armistice Capital, LLC and Steven Boyd, collectively the "Reporting Persons," have filed an Amendment No. 2 to Schedule 13G.
The filing indicates that as of September 30, 2025, the Reporting Persons beneficially own 0.00% of the Common stock of STAAR SURGICAL CO.
This represents a complete divestment of their previous holdings in the company.
The percentage of shares is based on 49,741,953 shares outstanding as of October 31, 2025, as reported in the Issuer's Form 10-Q filed on November 5, 2025.
Armistice Capital, LLC acts as the investment manager for Armistice Capital Master Fund Ltd., which was the direct holder of the shares.

Sentiment

Score: 2

Explanation: The complete divestment by a significant institutional investor is a strong negative signal, indicating a lack of confidence in the company's future prospects from that investor's perspective.

Negatives

Armistice Capital, LLC and Steven Boyd have completely divested their beneficial ownership in STAAR SURGICAL CO.
The Reporting Persons now hold 0.00% of the company's common stock, indicating a full exit from their investment.

Risks

The complete divestment by a significant institutional investor like Armistice Capital could signal a lack of confidence in STAAR SURGICAL CO.'s future prospects.
This action might lead to negative market sentiment and potential downward pressure on the company's stock price.

Future Outlook

No future outlook or guidance is provided by STAAR Surgical Co. in this investor filing.

Industry Context

This filing primarily reflects an investment decision by a specific fund rather than broader industry trends. However, a significant divestment by an institutional investor in the medical device or ophthalmology sector (where STAAR Surgical operates) could be interpreted by some as a signal regarding the company's specific performance or outlook within that industry.

Stakeholder Impact

Shareholders: Existing shareholders may experience decreased confidence and potential downward pressure on the stock price due to the complete divestment by a significant institutional investor.
Potential Investors: May view the divestment as a negative signal, potentially deterring new investment.

Key Dates

Date	Description
2025-09-30	Date of event which required the filing of this statement, indicating the point at which beneficial ownership changed to 0.00%.
2025-10-31	Date as of which 49,741,953 shares of STAAR Surgical Co. common stock were reported outstanding.
2025-11-05	Date STAAR Surgical Co. filed its Form 10-Q, reporting shares outstanding.
2025-11-14	Date the Schedule 13G/A Amendment No. 2 was signed and filed by Armistice Capital, LLC and Steven Boyd.

Recommendation

sell

The complete divestment by a significant institutional investor like Armistice Capital, LLC, and its managing member, Steven Boyd, signals a strong lack of confidence in STAAR Surgical Co.'s future performance. This action suggests that the investor no longer sees value or growth potential in the company, which is a significant negative indicator for other investors. Such a move often precedes or accompanies a decline in stock price, making a 'sell' recommendation prudent for those holding the stock, or a 'strong sell' for those considering it.

Keywords

STAAR Surgical, Armistice Capital, Steven Boyd, Schedule 13G, beneficial ownership, divestment, institutional investor, common stock, SEC filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.